CDX2 and breast carcinoma: The characteristic immunophenotypic profile of CK7+/CK20- combined with GATA3+/CDX2- or GATA3+/SATB2- patterns provides definitive evidence supporting metastatic breast carcinoma to gastrointestinal sites (32).